Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization
- PMID: 20236519
- PMCID: PMC2845138
- DOI: 10.1186/1477-7827-8-26
Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization
Abstract
Background: There are still some patients who show poor response to ovarian stimulation prior to evidence of normal ovarian reserve in vitro fertilization. However, there are few studies about how to treat the unexpectedly ovarian poor responder in vitro fertilization. The main aim of this study evaluate the effect of prolonging administration follicle-stimulating hormone in woman with the unexpectedly ovarian poor responder in vitro fertilization on implantation rate, clinical pregnancy rate and live birth rate.
Methods: 922 patients subjected to IVF were divided into two groups according to the predicted criterion of ovarian poor response. 116 patients predicted poor response received the short protocol (group C). The others received the long protocol, among the latter, there were 149 patients undergoing unexpectedly ovarian poor response (group B) and 657 patients exhibited normal ovarian response (group A). The doses of gonadotropin, duration of administration, implantation rate, clinical pregnancy rate and live birth rate were recorded among three groups.
Results: The implantation rate of embryo, clinic pregnancy rate and delivery rate are similar between the group A and group B, while there are significant differences between the doses of gonadotropins (35.1 +/- 8.9 ampules vs.53.0 +/- 15.9 ampules) and the duration of administration (15.3 +/- 3.6D vs. 9.8 +/- 2.6D) of these two groups. There are no significant differences about clinical pregnancy rate and live birth rate between group B and group C.
Conclusion: Prolonging administration gonadotropin on the unexpectedly poor ovarian responders does not lower live birth rate in vitro fertilization.
Similar articles
-
Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization.Gynecol Endocrinol. 2013 Sep;29(9):846-50. doi: 10.3109/09513590.2013.813475. Epub 2013 Jul 18. Gynecol Endocrinol. 2013. PMID: 23865696 Clinical Trial.
-
Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?Fertil Steril. 2008 Jan;89(1):151-6. doi: 10.1016/j.fertnstert.2007.02.013. Epub 2007 May 4. Fertil Steril. 2008. PMID: 17482177 Clinical Trial.
-
A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.Fertil Steril. 2014 Jul;102(1):108-115.e1. doi: 10.1016/j.fertnstert.2014.03.044. Epub 2014 May 3. Fertil Steril. 2014. PMID: 24796766 Clinical Trial.
-
Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.Fertil Steril. 2011 Jun 30;95(8):2449-55. doi: 10.1016/j.fertnstert.2011.04.041. Epub 2011 May 7. Fertil Steril. 2011. PMID: 21550037 Review.
-
Regimen of ovarian stimulation affects oocyte and therefore embryo quality.Fertil Steril. 2016 Mar;105(3):560-570. doi: 10.1016/j.fertnstert.2016.01.022. Epub 2016 Jan 27. Fertil Steril. 2016. PMID: 26826273 Review.
Cited by
-
Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.J Endocrinol Invest. 2017 Feb;40(2):207-215. doi: 10.1007/s40618-016-0550-5. Epub 2016 Sep 23. J Endocrinol Invest. 2017. PMID: 27664102
References
-
- Muttukrishna S, Mcgarrigle H, Wakim R. Antral follicle count anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? Obstet Gynaecol. 2005;112:1384–1390. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical